Ocugen (OCGN) Return on Equity [ROE] (2015 - 2025)
Ocugen (OCGN) reported Return on Equity [ROE] of -769.29% for FY2025, down 615.02 percentage points from -154.27% in FY2024.
Powered by 
Analysis
Ocugen (OCGN) Return on Equity [ROE] (2015 - 2025) Analysis & Trends
Dating back to FY2015, Ocugen's Return on Equity [ROE] record includes 9 years.
- Return on Equity [ROE] has declined for three consecutive years, with a five-year change of -635.28 percentage points (FY2020 to FY2025).
- The FY2025 figure ranks as the lowest annual Return on Equity [ROE] in data going back to FY2015.
- According to Business Quant data, Return on Equity [ROE] came in at -154.27% in FY2024 (-39.85 pp), -114.42% in FY2023 (-15.92 pp), -98.50% in FY2022 (+5.03 pp) and -103.53% in FY2021 (+30.47 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Ocugen | 349.22 Mn | 165.73 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1,912.95% |
| Jun 30, 2025 | -603.43% |
| Mar 31, 2025 | -253.89% |
| Dec 31, 2024 | -155.48% |
| Sep 30, 2024 | -181.25% |
| Jun 30, 2024 | -218.79% |
| Mar 31, 2024 | -168.62% |
| Dec 31, 2023 | -145.04% |
| Sep 30, 2023 | -139.29% |
| Jun 30, 2023 | -137.64% |
| Mar 31, 2023 | -120.21% |
| Dec 31, 2022 | -105.80% |
| Sep 30, 2022 | -80.25% |
| Jun 30, 2022 | -56.85% |
| Mar 31, 2022 | -64.59% |
| Dec 31, 2021 | -58.53% |
| Sep 30, 2021 | -42.27% |
| Jun 30, 2021 | -57.66% |
| Mar 31, 2021 | -73.35% |
| Dec 31, 2020 | -121.33% |
API Access
Ocugen Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OCGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "OCGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OCGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();